7-80462270-T-C
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_001102386.3(GNAT3):āc.763A>Gā(p.Asn255Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,480 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001102386.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GNAT3 | NM_001102386.3 | c.763A>G | p.Asn255Asp | missense_variant | 7/8 | ENST00000398291.4 | NP_001095856.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GNAT3 | ENST00000398291.4 | c.763A>G | p.Asn255Asp | missense_variant | 7/8 | 1 | NM_001102386.3 | ENSP00000381339.3 | ||
CD36 | ENST00000435819.5 | c.-477-24197T>C | intron_variant | 2 | ENSP00000399421.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000403 AC: 1AN: 247972Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134514
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460480Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 726584
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 09, 2024 | The c.763A>G (p.N255D) alteration is located in exon 7 (coding exon 7) of the GNAT3 gene. This alteration results from a A to G substitution at nucleotide position 763, causing the asparagine (N) at amino acid position 255 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at